←Back to Expert Scholars
Translational Medicine / 转化医学ADC Lineage Targets
Maria Tria
PhD
🏢Merck Research Laboratories🌐USA
Translational Scientist
20
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Maria Tria works on translational research for next generation antibody drug conjugates targeting lineage antigens such as HER3 and CEACAM5. Her work supports biomarker driven development of ADCs in lung and other solid tumors. She connects preclinical platforms with clinical evaluation.
Share:
🧪Research Fields 研究领域
antibody drug conjugates
HER3
lineage targeting
biomarkers
translational research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Maria Tria 的研究动态
Follow Maria Tria's research updates
留下邮箱，当我们发布与 Maria Tria（Merck Research Laboratories）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment